These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 19244402

  • 1. Spironolactone ameliorates transplant vasculopathy in renal chronic transplant dysfunction in rats.
    Waanders F, Rienstra H, Boer MW, Zandvoort A, Rozing J, Navis G, van Goor H, Hillebrands JL.
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1072-9. PubMed ID: 19244402
    [Abstract] [Full Text] [Related]

  • 2. Mineralocorticoid receptor antagonism and aldosterone synthesis inhibition do not improve glomerulosclerosis and renal interstitial fibrosis in a model of chronic kidney allograft injury.
    Lahmer T, Hermans R, Schmaderer C, Chang J, Stock K, Lutz J, Heemann U, Baumann M.
    Kidney Blood Press Res; 2012 May; 35(6):561-7. PubMed ID: 22890233
    [Abstract] [Full Text] [Related]

  • 3. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
    Pérez-Rojas J, Blanco JA, Cruz C, Trujillo J, Vaidya VS, Uribe N, Bonventre JV, Gamba G, Bobadilla NA.
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
    [Abstract] [Full Text] [Related]

  • 4. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 5. Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months.
    González Monte E, Andrés A, Polanco N, Toribio MJ, Santana R, Gutiérrez Martínez E, González J, Ramírez E, Hernández A, Morales E, Praga M, Morales JM.
    Transplant Proc; 2010 Oct 28; 42(8):2899-901. PubMed ID: 20970564
    [Abstract] [Full Text] [Related]

  • 6. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy.
    Neto JS, Nakao A, Toyokawa H, Nalesnik MA, Romanosky AJ, Kimizuka K, Kaizu T, Hashimoto N, Azhipa O, Stolz DB, Choi AM, Murase N.
    Am J Physiol Renal Physiol; 2006 Feb 28; 290(2):F324-34. PubMed ID: 16131650
    [Abstract] [Full Text] [Related]

  • 7. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
    Cavallari LH, Fashingbauer LA, Camp JR, King ST, Geenen DL.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep 28; 9(3):146-53. PubMed ID: 18957385
    [Abstract] [Full Text] [Related]

  • 8. Renocortical mRNA expression of vasoactive factors during spironolactone protective effect in chronic cyclosporine nephrotoxicity.
    Pérez-Rojas JM, Derive S, Blanco JA, Cruz C, Martínez de la Maza L, Gamba G, Bobadilla NA.
    Am J Physiol Renal Physiol; 2005 Nov 28; 289(5):F1020-30. PubMed ID: 15998842
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
    Liu M, Gu M, Wu Y, Zhu P, Zhang W, Yin C, Zhang WJ.
    J Surg Res; 2009 Nov 28; 157(1):e117-27. PubMed ID: 19589538
    [Abstract] [Full Text] [Related]

  • 10. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP, Federspiel C, Helderman H, Fogo AB.
    Nephrol Dial Transplant; 2005 Dec 28; 20(12):2812-9. PubMed ID: 16221712
    [Abstract] [Full Text] [Related]

  • 11. Chronic blockade of angiotensin II action prevents glomerulosclerosis, but induces graft vasculopathy in experimental kidney transplantation.
    Smit-van Oosten A, Navis G, Stegeman CA, Joles JA, Klok PA, Kuipers F, Tiebosch AT, van Goor H.
    J Pathol; 2001 May 28; 194(1):122-9. PubMed ID: 11329151
    [Abstract] [Full Text] [Related]

  • 12. The effect of aldosterone antagonist in experimental nephropathy induced by cyclosporine A.
    Silva FM, Miorin LA, Sens YA.
    Ren Fail; 2008 May 28; 30(4):439-42. PubMed ID: 18569919
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec 28; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 14. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S, Wang-Rosenke Y, Scholl V, Binder E, Loof T, Khadzhynov D, Kawachi H, Shimizu F, Diekmann F, Budde K, Neumayer HH, Peters H.
    Am J Physiol Renal Physiol; 2008 Feb 28; 294(2):F440-9. PubMed ID: 18094032
    [Abstract] [Full Text] [Related]

  • 15. Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease.
    Sato A, Hayashi K, Saruta T.
    Am J Hypertens; 2005 Jan 28; 18(1):44-9. PubMed ID: 15691616
    [Abstract] [Full Text] [Related]

  • 16. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
    Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB.
    Kidney Int; 2000 Sep 28; 58(3):1219-27. PubMed ID: 10972684
    [Abstract] [Full Text] [Related]

  • 17. Renoprotective effects of the AGE-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats.
    Waanders F, van den Berg E, Nagai R, van Veen I, Navis G, van Goor H.
    Nephrol Dial Transplant; 2008 Feb 28; 23(2):518-24. PubMed ID: 17905804
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.
    Rienstra H, Katta K, Celie JW, van Goor H, Navis G, van den Born J, Hillebrands JL.
    PLoS One; 2010 Feb 05; 5(2):e9095. PubMed ID: 20140097
    [Abstract] [Full Text] [Related]

  • 19. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats.
    Heemann UW, Azuma H, Tullius SG, Mackenzie H, Brenner BM, Tilney NL.
    Transplantation; 1994 Dec 27; 58(12):1317-22. PubMed ID: 7528948
    [Abstract] [Full Text] [Related]

  • 20. Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.
    Hamar P, Lipták P, Heemann U, Iványi B.
    Transpl Int; 2005 Jul 27; 18(7):863-70. PubMed ID: 15948867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.